Cargando…

Continuous renal replacement therapy: are we getting the dose right?

Detalles Bibliográficos
Autores principales:	Martin, S, Al-Haddad, M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934441/ http://dx.doi.org/10.1186/cc8745

Ejemplares similares

Evaluation of microcirculation before and during continuous renal replacement therapy and the impact of dose prescription
por: Pipili, C, et al.
Publicado: (2012)

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Amino acid adherence in continuous renal replacement therapies
por: Rodrigues, MG, et al.
Publicado: (2005)

Preliminary report of an enoxaparin dose protocol based on anti-Xa activity in continuous renal replacement therapy
por: Costa, JLF, et al.
Publicado: (2007)

Tedizolid clearance by in vitro continuous renal replacement therapy model
por: Lewis, SJ, et al.
Publicado: (2015)

Protein losses and nitrogen balance during continuous renal replacement therapy
por: Hayami, H, et al.
Publicado: (2011)

Metabolic disturbances encountered during pediatric continuous renal replacement therapy
por: Soysal, D, et al.
Publicado: (2006)

Removal of inflammatory mediators by continuous renal replacement therapy in severe sepsis
por: Tomas, E, et al.
Publicado: (2009)

Determinants of renal recovery and mortality inpatients undergoing continuous renal replacement therapy in the ICU
por: Gleeson, PJ, et al.
Publicado: (2015)

Linezolid pharmacokinetics in critically ill patients with renal replacement therapy: comparison of equi-dose of continuous veno-venous haemofiltration with continuous veno-venous haemodiafiltration
por: Roger, C, et al.
Publicado: (2015)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Stability of citrate and calcium dosing in citrate renal replacement therapy
por: Sadaat, F, et al.
Publicado: (2015)

Recovery of renal function after acute kidney injury requiring continuous renal replacement therapy
por: Jung, HY, et al.
Publicado: (2014)

Elimination rates of electrolytes, vitamins and trace elements during continuous renal replacement therapy with citrate CVVHD: influence of treatment dose
por: Von Freyberg, P, et al.
Publicado: (2014)

Analysis of longitudinal oncology quality of life (QoL) data - are we getting it right?
por: Cocks, Kim, et al.
Publicado: (2013)

An audit of antibiotic dosing according to renal function or renal replacement therapy in critical care
por: Donnelly, KD, et al.
Publicado: (2011)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
por: Crippa, IA, et al.
Publicado: (2015)

Protein content with parenteral nutrition in critical and hospitalized patients with continuous renal replacement therapies
por: Baez, AV, et al.
Publicado: (2015)

Coagulopathy of liver disease does not increase the filter life during continuous renal replacement therapy
por: Agarwal, B, et al.
Publicado: (2009)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury
por: Shum, HP, et al.
Publicado: (2012)

Timing of continuous renal replacement therapies in acute kidney injury patients after cardiac surgery
por: Cardenas Campos, P, et al.
Publicado: (2015)

Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: a clinical experience
por: Turani, F, et al.
Publicado: (2013)

Optimal dose of renal replacement therapy in acute kidney injury: a meta-analysis
por: Van Wert, RJ, et al.
Publicado: (2009)

Systemic citrate load during continuous renal replacement therapy is not negligible and can be predicted using indirect methods
por: Zakharchenko, M, et al.
Publicado: (2011)

Timing of the initiation of continuous renal replacement therapy and clinical outcome in patients with severe sepsis and septic shock
por: Cho, S
Publicado: (2012)

Daily fluid balance predicts hospital mortality in critically ill patients receiving continuous renal replacement therapy
por: Kashiouris, M, et al.
Publicado: (2013)

Evaluation of functional differences between two anticoagulation methods used in continuous renal replacement therapy in critical patients
por: Goulão, V, et al.
Publicado: (2014)

Further mammographic views: the importance of getting it right
por: Dyson, S, et al.
Publicado: (2006)

Utilization of slow low-efficiency dialysis may help to optimize the need for continuous renal replacement therapy in Indian ICUs
por: Majumdar, A, et al.
Publicado: (2009)

Combined use of pumpless extracorporeal lung assist system and continuous renal replacement therapy with citrate anticoagulation in polytrauma patients
por: Atalan, HK, et al.
Publicado: (2013)

Weight gain a risk factor for mortality in patients with acute kidney injury requiring continuous renal replacement therapy
por: Maldonado Toral, C, et al.
Publicado: (2015)

Hybrid renal replacement techniques vs continuous haemodiafiltration in haemodynamically unstable patients
por: Marcelino, P, et al.
Publicado: (2006)

Renal replacement therapy for acute renal failure in the intensive care unit is associated with a worse prognosis than renal replacement therapy for end-stage renal failure
por: Ostermann, M, et al.
Publicado: (2005)

Continuous renal replacement therapy (CVVHD) for acute kidney injury in critical care: incidence and outcome across South West Wales
por: Brown, K, et al.
Publicado: (2014)

A comparison between 2 dilute citrate solutions (15mmol/l vs 18 mmol/l) in continuous renal replacement therapy: the base excess and renal replacement solution (BEARRS) study
por: Anstey, CM, et al.
Publicado: (2015)

High fluid volume removal with continuous renal replacement therapy as a therapeutic option for early posttraumatic acute respiratory distress syndrome
por: Sorrentino, L, et al.
Publicado: (2008)

Fluid balance and renal outcomes in patients requiring renal replacement therapy in the ICU
por: Silversides, JA, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3fc7rc3sf5se71on2njgblcm1b